journal
MENU ▼
Read by QxMD icon Read
search

Diabetes Spectrum: a Publication of the American Diabetes Association

journal
https://www.readbyqxmd.com/read/27899878/a-provider-s-perspective-on-the-management-of-diabetes-from-preschool-through-the-teen-years
#1
Jo Ann H Ahern
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899877/recognizing-and-appropriately-treating-latent-autoimmune-diabetes-in-adults
#2
Katherine S O'Neal, Jeremy L Johnson, Rebekah L Panak
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899876/several-aspects-of-internet-and-web-based-technology-in-diabetes-management
#3
Courtney L Spearson, Anahita Mistry
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899875/nutrition-considerations-for-microbiota-health-in-diabetes
#4
Meghan Jardine
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899874/management-of-adults-with-diabetes-and-cognitive-problems
#5
Rachel Hopkins, Kristi Shaver, Ruth S Weinstock
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899873/cognition-in-adults-and-older-adults-with-type-1-diabetes-chicken-or-egg
#6
Naomi S Chaytor
IN BRIEF Cognitive impairment and cognitive decline are common in adults with type 1 diabetes. Although several diabetes-related variables have been associated with cognitive functioning in both cross-sectional and longitudinal studies, inconsistencies remain. This is particularly true in older adults. Cognitive impairment appears to be both a consequence of and a risk factor for poor diabetes self-management and associated glycemic outcomes. Interventions such as cognitive compensatory strategies, assistive technology, and simplified treatment regimens may limit the impact of cognitive impairment on self-management in adults and older adults with type 1 diabetes...
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899872/type-2-diabetes-cognition-and-dementia-in-older-adults-toward-a-precision-health-approach
#7
Brenna Cholerton, Laura D Baker, Thomas J Montine, Suzanne Craft
IN BRIEF There has been a concurrent dramatic rise in type 2 diabetes and dementia in the United States, and type 2 diabetes shares common genetic and environmental risk factors and underlying pathology with both vascular and Alzheimer's dementias. Given the ability to identify this at-risk population and a variety of potential targeted treatments, type 2 diabetes represents a promising focus for a precision health approach to reduce the impact of cognitive decline and dementia in older adults.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899871/screening-of-neurocognitive-and-executive-functioning-in-children-adolescents-and-young-adults-with-type-1-diabetes
#8
Rachel M Wasserman, Barbara J Anderson, David D Schwartz
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899870/cognition-and-type-1-diabetes-in-children-and-adolescents
#9
Allison Cato, Tamara Hershey
IN BRIEF In children and adolescents with type 1 diabetes, exposure to glycemic extremes (severe hypoglycemia, chronic hyperglycemia, and diabetic ketoacidosis) overlaps with the time period of most active brain and cognitive development, leading to concerns that these children are at risk for cognitive side effects. This article summarizes the existing literature examining the impact of glycemic extremes on cognitive function and brain structure in youth with type 1 diabetes and points out areas for future research...
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899869/guest-editor
#10
EDITORIAL
(no author information available yet)
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27899868/cognition-and-diabetes-across-the-life-span-preface
#11
Naomi Chaytor
No abstract text is available yet for this article.
November 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574377/erratum-mystkowski-p-neumiller-jj-prandial-insulin-dosing-how-long-does-it-take-to-go-80-miles-diabetes-spectrum-2016-29-67-69-doi-10-2337-diaspect-29-2-67
#12
(no author information available yet)
[This corrects the article on p. 67 in vol. 29, PMID: 27182172.].
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574376/erratum-blum-ak-insulin-use-in-pregnancy-an-update-diabetes-spectrum-2016-29-92-97-doi-10-2337-diaspect-29-2-92
#13
(no author information available yet)
[This corrects the article on p. 92 in vol. 29, PMID: 27182178.].
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574375/cultural-differences-and-considerations-when-initiating-insulin
#14
Julio A Rebolledo, Regina Arellano
No abstract text is available yet for this article.
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574374/commentary-why-was-inhaled-insulin-a-failure-in-the-market
#15
Jacob Oleck, Shahista Kassam, Jennifer D Goldman
No abstract text is available yet for this article.
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574373/a-novel-approach-to-the-management-of-neonatal-diabetes-using-sensor-augmented-insulin-pump-therapy-with-threshold-suspend-technology-at-diagnosis
#16
Monica T Marin, Michael L Coffey, Joni K Beck, Paul S Dasari, Rebecca Allen, Sowmya Krishnan
No abstract text is available yet for this article.
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574372/what-the-latest-evidence-tells-us-about-fat-and-cardiovascular-health
#17
Joy Hayes, Gretchen Benson
No abstract text is available yet for this article.
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574371/adherence-to-insulin-therapy
#18
G Blair Sarbacker, Elizabeth M Urteaga
IN BRIEF Six million people with diabetes use insulin either alone or in combination with an oral medication. Many barriers exist that lead to poor adherence with insulin. However, there is an underwhelming amount of data on interventions to address these barriers and improve insulin adherence. Until pharmacological advancements create easier, more acceptable insulin regimens, it is imperative to involve patients in shared decision-making.
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574370/the-future-of-biosimilar-insulins
#19
Anne Park Kim, Ross Jason Bindler
IN BRIEF Biosimilar insulins are available in many countries and will be made available in the United States in the near future. Some concerns associated with biosimilar insulins include potential differences in the efficacy and safety between a biosimilar product and its reference insulin, the ramifications of having the same name or different names for a biosimilar and its reference insulin, the prospects of and limitations to substituting insulin products, and the proper implementation of pharmacovigilance...
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/27574369/basal-insulin-use-with-glp-1-receptor-agonists
#20
Sarah L Anderson, Jennifer M Trujillo
IN BRIEF The combination of basal insulin and a glucagon-like peptide 1 receptor agonist is becoming increasingly common and offers several potential benefits to patients with type 2 diabetes. Clinical studies have demonstrated improved glycemic control and low risks of hypoglycemia and weight gain with the combination, which provides a safe and effective alternative to basal-bolus insulin with less treatment burden. Fixed-ratio combination products that administer both agents in a single injection are in the pipeline and will offer additional options for clinicians and patients...
August 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
journal
journal
30215
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"